Case number 1:23-cv-00556
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 14, 2024 | 41 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,415,053 B2. (Attachments: # 1 Notice of Voluntary Dismissal)(nms) (Entered: 03/14/2024) (0) |
| Mar 14, 2024 | 40 | NOTICE of Voluntary Dismissal by Mylan Pharmaceuticals Inc. as to all claims asserted, without prejudice (Palapura, Bindu) (Entered: 03/14/2024) (1) |
| Feb 27, 2024 | 39 | STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 2/27/2024 (nms). (Entered: 02/27/2024) (2) |
| Feb 15, 2024 | 38 | ORDER: The Report and Recommendation (D.I. 37 ) is ADOPTED. Defendants' motion to dismiss, or alternatively to stay (D.I. 18 ) is DENIED. Signed by Judge Richard G. Andrews on 2/15/2024. (nms) (Entered: 02/15/2024) (1) |
| Jan 31, 2024 | 37 | REPORT AND RECOMMENDATIONS re 18 Denying the MOTION to Dismiss This Action for Lack of Subject-Matter Jurisdiction or, Alternatively, to Stay filed by Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Intellectual Property GMBH. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 2/14/2024. Signed by Judge Laura D. Hatcher on 1/31/24. (kjk) (Entered: 01/31/2024) (21) |
| Dec 22, 2023 | 36 | NOTICE requesting Clerk to remove Elham Firouzi Steiner as co-counsel. Reason for request: No longer with the firm of Wilson Sonsini Goodrich & Rosati. (Moore, David) (Entered: 12/22/2023) (1) |
| Nov 7, 2023 | 35 | SO ORDERED Granting 34 MOTION and Proposed Order Granting Limited Exemption From the Standing Order Regarding Personal Electronic Devices. Signed by Judge Richard G. Andrews on 11/7/2023. (nms) (Entered: 11/07/2023) (2) |
| Nov 7, 2023 | 34 | MOTION and Proposed Order Granting Limited Exemption From the Standing Order Regarding Personal Electronic Devices - filed by Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 11/7/2023 (nms). (Entered: 11/07/2023) (2) |
| Oct 27, 2023 | 33 | Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding the parties' response to the Court's October 17, 2023 Oral Order. (Fahnestock, Derek) Modified on 10/27/2023 (nms). (Entered: 10/27/2023) (1) |
| Oct 17, 2023 | 32 | ORAL ORDER. The Court requests that the parties consider consenting to Judge Hatchers jurisdiction over the pending motion (D.I.18). Thus, it is ordered that, should the parties consent to Judge Hatchers jurisdiction over the motion, they should complete the attached form and email it to Nicole_Selmyer@ded.uscourts.gov. If the parties do not consent to Judge Hatchers jurisdiction, they shall file a letter stating such no later than October 31, 2023. The letter should in no way inform the Court which party or parties declined to consent. Ordered by Judge Laura D. Hatcher on 10/17/23. (kjk) (kjk). (Entered: 10/18/2023) (1) |
| Oct 17, 2023 | 31 | ORAL ORDER Setting a Hearing on Motion: A hearing on the pending Motion to Dismiss This Action for Lack of Subject-Matter Jurisdiction or, Alternatively, to Stay (D.I. 18) is scheduled for Wednesday, November 8, 2023 at 1:00pm in Courtroom 2B before Judge Laura D. Hatcher. Signed by Judge Laura D. Hatcher on 10/17/23. (kjk) (Entered: 10/18/2023) (0) |
| Oct 9, 2023 | 30 | REQUEST for Oral Argument by Mylan Pharmaceuticals Inc. re 18 MOTION to Dismiss This Action for Lack of Subject-Matter Jurisdiction or, Alternatively, to Stay. (Palapura, Bindu) (Entered: 10/09/2023) (1) |
| Oct 6, 2023 | 29 | NOTICE requesting Clerk to remove Ty W. Callahan as co-counsel. Reason for request: No longer with the firm of Wilson Sonsini Goodrich & Rosati. (Moore, David) (Entered: 10/06/2023) (1) |
| Oct 5, 2023 | 28 | Letter to The Honorable Laura D. Hatcher, from Derek J. Fahnestock, regarding request for oral argument. (Fahnestock, Derek) Modified on 10/5/2023 (nms). (Entered: 10/05/2023) (1) |
| Oct 4, 2023 | 27 | ORAL ORDER: The Motion to Dismiss This Action for Lack of Subject-Matter Jurisdiction or, Alternatively, to Stay (D.I. 18 ) is now REFERRED to Magistrate Judge Laura D. Hatcher. Ordered by Judge Richard G. Andrews on 10/4/2023. (nms) (Entered: 10/04/2023) (0) |
| Sep 29, 2023 | 26 | REPLY BRIEF re 18 MOTION to Dismiss This Action for Lack of Subject-Matter Jurisdiction or, Alternatively, to Stay, filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A)(Fahnestock, Derek) Modified on 10/2/2023 (nms). (Entered: 09/29/2023) (0) |
| Sep 15, 2023 | 25 | ANSWERING BRIEF in Opposition re 18 MOTION to Dismiss This Action for Lack of Subject-Matter Jurisdiction or, Alternatively, to Stay, filed by Mylan Pharmaceuticals Inc.. Reply Brief due date per Local Rules is 9/22/2023. (Attachments: # 1 Exhibits A-D)(Moore, David) Modified on 9/17/2023 (nms). (Entered: 09/15/2023) (0) |
| Sep 5, 2023 | 24 | MOTION for Pro Hac Vice Appearance of Attorney Dov P. Grossman, Alexander S. Zolan, and Ben Picozzi - filed by Bayer AG, Bayer Intellectual Property GMBH. (Fahnestock, Derek) (Entered: 09/05/2023) (6) |
| Sep 1, 2023 | 23 | STIPULATION and Proposed Order to Extend Time - filed by Mylan Pharmaceuticals Inc.. (Brown, Andrew) Modified on 9/1/2023 (nms). (Entered: 09/01/2023) (2) |
| Aug 28, 2023 | 22 | REDACTED VERSION of 19 Opening Brief in Support, by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Fahnestock, Derek) Modified on 8/29/2023 (nms). (Entered: 08/28/2023) (0) |
| Aug 24, 2023 | 21 | 7.1.1 Statement for Motion to Seal (D.I. 17 ), by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/25/2023 (nms). (Entered: 08/24/2023) (2) |
| Aug 22, 2023 | 20 | ORDER Granting 17 MOTION to Seal. Signed by Judge Richard G. Andrews on 8/22/2023. (nms) (Entered: 08/22/2023) (1) |
| Aug 21, 2023 | 19 | [SEALED] OPENING BRIEF in Support re 18 MOTION to Dismiss This Action for Lack of Subject-Matter Jurisdiction or, Alternatively, to Stay, filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 9/5/2023. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Smith, Rodger) Modified on 8/21/2023 (nms). (Entered: 08/21/2023) (0) |
| Aug 21, 2023 | 18 | MOTION to Dismiss This Action for Lack of Subject-Matter Jurisdiction or, Alternatively, to Stay - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Smith, Rodger) Modified on 8/21/2023 (nms). (Entered: 08/21/2023) (4) |
| Aug 21, 2023 | 17 | MOTION to Seal - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Smith, Rodger) Modified on 8/21/2023 (nms). (Entered: 08/21/2023) (6) |
| Jun 14, 2023 | 16 | MOTION for Pro Hac Vice Appearance of Attorney T.O. Kong, Wendy L. Devine, Elham Firouzi Steiner and Ty W. Callahan of Wilson Sonsini Goodrich & Rosati P.C. - filed by Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 06/14/2023) (6) |
| Jun 6, 2023 | 15 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 06/06/2023) (2) |
| Jun 6, 2023 | 14 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH; Corporate Parent no parent corporation for Bayer AG filed by Bayer AG, Bayer Intellectual Property GMBH. (Fahnestock, Derek) (Entered: 06/06/2023) (2) |
| Jun 6, 2023 | 13 | STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/7/2023 (nms). (Entered: 06/06/2023) (2) |
| Jun 2, 2023 | 12 | WAIVER OF SERVICE returned executed by Mylan Pharmaceuticals Inc.: For Bayer AG waiver sent on 5/23/2023, answer due 8/21/2023. (Moore, David) (Entered: 06/02/2023) (1) |
| Jun 2, 2023 | 11 | WAIVER OF SERVICE returned executed by Mylan Pharmaceuticals Inc.: For Bayer Intellectual Property GMBH waiver sent on 5/23/2023, answer due 8/21/2023. (Moore, David) (Entered: 06/02/2023) (1) |
| Jun 2, 2023 | 10 | WAIVER OF SERVICE returned executed by Mylan Pharmaceuticals Inc.: For Janssen Pharmaceuticals, Inc. waiver sent on 5/23/2023, answer due 7/24/2023. (Moore, David) (Entered: 06/02/2023) (1) |
| May 25, 2023 | 9 | Letter to Clerk of Court, from David E. Moore, regarding the remark entered on the docket regarding MDL affiliation. (Moore, David) Modified on 5/25/2023 (nms). (Entered: 05/25/2023) (1) |
| May 22, 2023 | 8 | [SEALED] EXHIBIT B to 2 Complaint, by Mylan Pharmaceuticals Inc.. (nms) (Entered: 05/22/2023) (0) |
| May 22, 2023 | 7 | ORAL ORDER: The Motion for Leave to File Complaint and Exhibit B Under Seal (D.I. 1 ) is GRANTED in part and DENIED in part. The request to seal the complaint is DENIED and the request to file Exhibit B under seal is GRANTED. Ordered by Judge Richard G. Andrews on 5/22/2023. (nms) (Entered: 05/22/2023) (0) |
| May 19, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent's Mylan Inc. and Viatris Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc. (jdb) (Entered: 05/22/2023) (2) |
| May 19, 2023 | 5 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,415,053 B2. (jdb) (Entered: 05/22/2023) (1) |
| May 19, 2023 | 4 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/14/2018. Date of Expiration of Patent: 11/13/2024. (jdb) (Entered: 05/22/2023) (1) |
| May 19, 2023 | 3 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jdb) (Entered: 05/22/2023) (3) |
| May 19, 2023 | 2 | Complaint* (1) |
